2m 2m 2m 2m 2m 2m 2m
Regen BioPharma (RGBP)
OTC
$0.0002-$0.00005 (-18.64%)
Price as of Jun 02, 2026- $153,587.00Market Cap
- -98.95%1-Year Change
- BiotechnologyIndustry
Regen BioPharma (RGBP)
$0.0002-$0.00005 (-18.64%)
RGBP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.00 | ||
Change | -$0.00005 (-18.64%) | ||
Open | $0.00 | ||
High | $0.00 | ||
Low | $0.00 | ||
Previous Close | $0.00 | ||
Volume | 3,099,077 | ||
30-Day Average Volume | 15,065,817 | ||
1-Week Change | -20.00% | ||
1-Month Change | -31.43% | ||
1-Year Change | -98.95% | ||
3-Year Change | -99.86% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 512.0M | ||
Total Assets | $260,194.00 | ||
Market Cap | $153,587.00 | ||
Enterprise Value | $1.5M | ||
Period: QTR TTM FY | |||
Revenue | $31,640.00 | ||
Net Income | $991,927.00 | ||
Free Cash Flow | -$63,234.00 | ||
EBIT | $991,927.00 | ||
EBITDA | $991,927.00 | ||
Net Working Capital | -$5.4M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | 2 | ||
Enterprise Value/Revenue | 48 | ||
P/B | -0 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 2 : 1 | ||
Last Split Date | 02/10/2026 | ||
Earnings & Revenue